Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
Clinical trial NCT02153502 · COMPLETED
Trial details
- NCT number
- NCT02153502
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2016-02-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.